MMP9 and familial pancreatic carcinoma: After treatment with bevacizumab (a VEGF inhibitor) and doxycycline (a drug that can effectively inhibit angiogenesis like an MMP-9 inhibitor) for 14 days, the tumor volume in pancreatic cancer mice significantly decreased.